Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians-Reference-Cited by-同舟云学术

Entecavir treatment does not eliminate the risk of hepatocellular carcinoma in chronic hepatitis B: limited role for risk scores in Caucasians

Published:2014-07-10 Issue:8 Volume:64 Page:1289-1295
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Arends Pauline,Sonneveld Milan J,Zoutendijk Roeland,Carey Ivana,Brown Ashley,Fasano Massimo,Mutimer David,Deterding Katja,Reijnders Jurriën G P,Oo Ye,Petersen Jörg,van Bömmel Florian,de Knegt Robert J,Santantonio Teresa,Berg Thomas,Welzel Tania M,Wedemeyer Heiner,Buti Maria,Pradat Pierre,Zoulim Fabien,Hansen Bettina,Janssen Harry L A

Publisher

BMJ

Subject

Gastroenterology

Reference13 articles.

1. Hepatitis B virus infection;Dienstag;N Engl J Med,2008

2. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;European Association For The Study Of The Liver;J Hepatol,2012

3. Chronic hepatitis B: update 2009;Lok;Hepatology,2009

4. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level;Chen;JAMA,2006

5. Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B;Chang;Hepatology,2010

Cited by 177 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Risk Factors and Scoring Systems Associated with the Development of Hepatocellular Carcinoma in Chronic Hepatitis B;Cancers;2024-07-12

2. Lack of association between early on-treatment HBeAg seroclearance and development of hepatocellular carcinoma or decompensated cirrhosis;JHEP Reports;2024-07

3. Treatment decisions based on HBV DNA;Journal of Viral Hepatitis;2024-05-24

4. Development and Validation of a Machine Learning-Based Model Used for Predicting Hepatocellular Carcinoma Risk in Patients with Hepatitis B-Related Cirrhosis: A Retrospective Study;OncoTargets and Therapy;2024-03

5. Hepatocellular carcinoma risk in sub-Saharan African and Afro-Surinamese individuals with chronic hepatitis B living in Europe;Journal of Hepatology;2024-02